DROPPING TODAY Biotechnology $68M Cap Quant: EXTENDED

Why Is aTyr Pharma, Inc. (ATYR) Stock Down Today?

Updated Nov 17, 2026 7:30 PM ET · Prev Close $5.24

Pro Workspace
Last Session Price
$4.93 -5.92%
-$0.31 vs $5.24 prior close
Intraday Range
$4.70 – $5.41
Open $5.31
Relative Volume
0.10x Avg
108,119 sh
52-Week Range
$4.32 – $7.98
Benchmark Alpha
-5.01% vs SPY
-5.13% vs QQQ
20-Session Trend -8.2%

Primary Move Catalyst & Conviction

65% Signal Conviction
SECTOR 65% Driver Weight

Biotechnology & Biological Products sector moving together

This appears to be a sector-wide move. The Biotechnology & Biological Products sector is down 2.2% on average.

Volume Confirmation
LOW VOLUME (0.10x) Unconfirmed
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 65%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

ATYR lagging the S&P 500 by -5.01%
ATYR Session
-5.92%
$4.93
S&P 500 (SPY)
-0.91%
$733.21
Nasdaq 100 (QQQ)
-0.79%
$656.55
Healthcare (XLV)
-0.94%
$186.12
Alpha vs SPY: -5.01% Alpha vs QQQ: -5.13% Alpha vs XLV: -4.98%
Peer Group: Biotechnology & Biological Products (-2.3% avg) Lagging peers by -3.7%

Options Flow & Execution Desk

Bullish Flow · P/C 0.13
Call Volume
10,443
Contracts
Put Volume
1,338
Contracts
Put / Call Ratio
0.13
11,781 total vol
Implied Volatility
215.7%
Chain avg IV

Recent ATYR Catalyst Headlines

Verified Wire
aTyr Pharma to Participate in Upcoming Investor Conferences

San Diego, Nov. 11, 2026 Globe Newswire -- aTyr Pharma, Inc. Nasdaq ATYR , a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase

Yahoo Finance · Nov 11, 2026

1–3 Day Expected Range & Key Level

45% Follow-Through
Lower Bound
$4.78
Short-term support band
Upper Bound
$5.03
Short-term resistance band
Key Inflection Level
$4.68 (support)

Watch for breakdown below $4.93

Technical Regime (ATYR)

RSI (14)
57.9
Bullish
MACD Signal
Bearish
MACD 1.36
ADX (14)
61.5
Strong trend
10d Momentum
-1.63
Soft 10-day momentum

1-Year Historical Move Analogs

5 Events

Sessions in the past year where ATYR moved >3.0% down:

Continuation Rate
80.0%
4/5 sessions
Avg Next-Day Move
+1.8%
T+1 session return
Last analog: Nov 16, 2026 (-14.2%) → Next session: -5.9%

Retail & Crowd Sentiment

Neutral
24h Messages
0
7d avg 0.7
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

Moderna's international revenue reached $900 million in the first nine months of 2026, making up about 40% of third-quarter revenue. Moderna earned an operating profit in the third quarter of 2026, but still lost money on operations over the last twelve months.

Reddit communities: 1 comment (Neutral)

About aTyr Pharma, Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality an...

Sector
Healthcare
Market Cap
$68M
Employees
59

Get Instant ATYR Catalyst Alerts

Receive an email alert when ATYR triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

ATYR Session & Catalyst FAQ

Why is ATYR stock down today?

This appears to be a sector-wide move. The Biotechnology & Biological Products sector is down 2.2% on average.

Is ATYR stock a buy or sell right now?

Today's session carries a 65% catalyst conviction score on 0.10x relative volume (low participation). Our multi-factor model currently rates ATYR as EXTENDED. Review full valuation, quality, and timing signals on the ATYR Buy or Sell Decision Brief →

What is ATYR's intrinsic value and expected trading range?

At $4.93, ATYR's modeled 1-to-3 session range is $4.78 – $5.03, with a key inflection level at $4.68 (support). Compare current price against multi-year cash flow projections in the ATYR Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for ATYR?

RSI at 57.9 reflects constructive bullish momentum.

Tradestie Flagship Research & Market Hubs